Markets/EquitiesArticle

Lilly to present cardiometabolic drug data at EASD conference

Eli Lilly will present cardiometabolic drug data at the upcoming EASD conference.

PA

Priya Anand · Equities & Earnings Desk · 15 Sept 2026 · 12:21 · 1 min read

Share

Lilly to present cardiometabolic drug data at EASD conference

Eli Lilly announced it will present cardiometabolic drug data at the EASD conference.

Further details were not immediately available.

Companies Healthcare

This article was produced with AI assistance and edited by a Finance Review Daily journalist.

Novara — A Smarter Way to Access Global Markets

Share this story

PA

Written by

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Market Snapshot

Delayed

EUR/USD1.1535▼ 0.14%GBP/USD1.3482▼ 0.14%USD/CHF0.8178▲ 0.06%BTC/USD77,038.3▼ 1.47%ETH/USD2,475.26▼ 1.61%XAU/USD4,274.82▼ 0.55%

Beximco Pharmaceuticals eyes board shake-up in bid to settle Bangladesh court disputes

Priya Anand · 42 min ago

Lilly to present cardiometabolic drug data at EASD conference

Market Snapshot

Related Reading

Big Ridge Gold Names Ex-Maritime Resources CEO Garett Macdonald to Board

Driven Brands Sets 2-3x Leverage Target, Authorizes $100M Buyback

Brunswick sees strong dealer demand at Cannes boat show

Kromek Chairman Buys 145K Shares at 6.88p

Beximco Pharmaceuticals eyes board shake-up in bid to settle Bangladesh court disputes